Halozyme Therapeutics HALO
NASDAQ HALO
$110.52 -1.04 (-0.93%)
As of: Sep 30, 2026 · 3:58 PM EDT

Halozyme Therapeutics (HALO) Current Assets (2010 - 2026)

Updated

Halozyme Therapeutics' Current Assets came in at $933.02 million for Q2 2026, down 16.9% from $1.12 billion a year earlier and down 7.0% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Halozyme Therapeutics' Current Assets was $825.21 million, down 24.0% from FY2024.

  • Current Assets carries a five-year compound annual growth rate of 8.3% (FY2020 to FY2025).
  • Going back by year, Current Assets was $1.09 billion in FY2024 (+45.4%), $746.42 million in FY2023 (+1.0%), $739.01 million in FY2022 (-20.2%) and $926.29 million in FY2021 (+67.0%).
  • The five-year range for quarterly Current Assets is $541.94 million (Q2 2022) to $1.33 billion (Q3 2025).
  • Year-over-year, Current Assets has declined for three consecutive quarters, with growth averaging 11.0% over the last eight quarters.
  • The fastest year-over-year change in Current Assets over five years came in Q3 2021 (growth of 103.9%), and the weakest in Q2 2022 (a decline of 45.8%).
  • Business Quant data shows HALO's Current Assets at $1 billion (Q1 2026), $825.21 million (Q4 2025) and $1.33 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 59.77 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 33.67 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 27.97 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 12.54 Bn
10 Halozyme Therapeutics 12.72 Bn 11.33 Bn 401.83 Mn 933.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 933.02 Mn
Mar 31, 2026 1.00 Bn
Dec 31, 2025 825.21 Mn
Sep 30, 2025 1.33 Bn
Jun 30, 2025 1.12 Bn
Mar 31, 2025 1.26 Bn
Dec 31, 2024 1.09 Bn
Sep 30, 2024 1.13 Bn
Jun 30, 2024 987.80 Mn
Mar 31, 2024 873.58 Mn
Dec 31, 2023 746.42 Mn
Sep 30, 2023 879.01 Mn
Jun 30, 2023 765.75 Mn
Mar 31, 2023 615.02 Mn
Dec 31, 2022 739.01 Mn
Sep 30, 2022 653.20 Mn
Jun 30, 2022 541.94 Mn
Mar 31, 2022 988.69 Mn
Dec 31, 2021 926.29 Mn
Sep 30, 2021 1.02 Bn
API Access

Halozyme Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=HALO&period=max&api_key=YOUR_API_KEY